Progyny Inc
NASDAQ:PGNY

Watchlist Manager
Progyny Inc Logo
Progyny Inc
NASDAQ:PGNY
Watchlist
Price: 15.44 USD 3.14% Market Closed
Market Cap: 1.4B USD
Have any thoughts about
Progyny Inc?
Write Note

Progyny Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Progyny Inc
Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Progyny Inc
NASDAQ:PGNY
Operating Expenses
-$181.4m
CAGR 3-Years
-35%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
UnitedHealth Group Inc
NYSE:UNH
Operating Expenses
-$361.7B
CAGR 3-Years
-12%
CAGR 5-Years
-10%
CAGR 10-Years
-12%
Centene Corp
NYSE:CNC
Operating Expenses
-$13.7B
CAGR 3-Years
51%
CAGR 5-Years
28%
CAGR 10-Years
0%
Molina Healthcare Inc
NYSE:MOH
Operating Expenses
-$4.7B
CAGR 3-Years
-18%
CAGR 5-Years
-19%
CAGR 10-Years
-15%
Humana Inc
NYSE:HUM
Operating Expenses
-$111.6B
CAGR 3-Years
-13%
CAGR 5-Years
-13%
CAGR 10-Years
-10%
Elevance Health Inc
NYSE:ELV
Operating Expenses
-$164.8B
CAGR 3-Years
-9%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
No Stocks Found

Progyny Inc
Glance View

Market Cap
1.4B USD
Industry
Health Care

Progyny, Inc. is a fertility benefits management company. The company is headquartered in New York City, New York and currently employs 311 full-time employees. The company went IPO on 2019-10-25. The firm specializes in fertility and family building benefits solutions in the United States. The firm provides its benefit through its Smart Cycle approach. The Smart Cycle includes medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition, to its fertility benefits solution, it offers an integrated pharmacy benefits solution, Progyny Rx, which is added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. As part of this solution, the Company provide care management services, which include its formulary plan design, simplified authorization, assistance with prescription fulfillment and timely delivery of the medications by its network of specialty pharmacies, as well as medication administration training, pharmacy support services and patient care advocates.

PGNY Intrinsic Value
38.38 USD
Undervaluation 60%
Intrinsic Value
Price

See Also

What is Progyny Inc's Operating Expenses?
Operating Expenses
-181.4m USD

Based on the financial report for Sep 30, 2024, Progyny Inc's Operating Expenses amounts to -181.4m USD.

What is Progyny Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-42%

Over the last year, the Operating Expenses growth was -4%. The average annual Operating Expenses growth rates for Progyny Inc have been -35% over the past three years , -42% over the past five years .

Back to Top